173 related articles for article (PubMed ID: 24991188)
61. Tumor-specific T-cell clones recognize different protein determinants of autologous human malignant melanoma cells.
Notter M; Schirrmacher V
Int J Cancer; 1990 May; 45(5):834-41. PubMed ID: 2159436
[TBL] [Abstract][Full Text] [Related]
62. Vogt-Koyanagi-Harada disease: inquiry into the genesis of a disease name in the historical context of Switzerland and Japan.
Herbort CP; Mochizuki M
Int Ophthalmol; 2007; 27(2-3):67-79. PubMed ID: 17468832
[TBL] [Abstract][Full Text] [Related]
63. Vogt-Koyanagi-Harada syndrome.
Greco A; Fusconi M; Gallo A; Turchetta R; Marinelli C; Macri GF; De Virgilio A; de Vincentiis M
Autoimmun Rev; 2013 Sep; 12(11):1033-8. PubMed ID: 23567866
[TBL] [Abstract][Full Text] [Related]
64. Vogt-Koyanagi-Harada-like Syndrome Complicating Pembrolizumab Treatment for Metastatic Melanoma.
Bricout M; Petre A; Amini-Adle M; Bezza W; Seve P; Kodjikian L; Dalle S; Thomas L
J Immunother; 2017; 40(2):77-82. PubMed ID: 28166182
[TBL] [Abstract][Full Text] [Related]
65. Cytotoxic T lymphocyte reactivity to gp100, MelanA/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients.
Mandelcorn-Monson RL; Shear NH; Yau E; Sambhara S; Barber BH; Spaner D; DeBenedette MA
J Invest Dermatol; 2003 Sep; 121(3):550-6. PubMed ID: 12925214
[TBL] [Abstract][Full Text] [Related]
66. Increased Expression of Indoleamine 2,3-Dioxygenase (IDO) in Vogt-Koyanagi-Harada (VKH) Disease May Lead to a Shift of T Cell Responses Toward a Treg Population.
Zhang L; Huang Y; Cui X; Tan X; Zhu Y; Zhou W; Wang C; Yuan G; Cao Q; Su G; Kijlstra A; Yang P
Inflammation; 2020 Oct; 43(5):1780-1788. PubMed ID: 32435912
[TBL] [Abstract][Full Text] [Related]
67. [The association of HLA-DR4 gene subtypes with Vogt-Koyanagi-Harada syndrome].
Xiao T; Jiang Y; You X
Zhonghua Yan Ke Za Zhi; 1997 Jul; 33(4):268-71. PubMed ID: 10451958
[TBL] [Abstract][Full Text] [Related]
68. Ultrastructural changes in rat eyes with experimental Vogt-Koyanagi-Harada disease.
Hayakawa K; Ishikawa M; Yamaki K
Jpn J Ophthalmol; 2004; 48(3):222-7. PubMed ID: 15175913
[TBL] [Abstract][Full Text] [Related]
69. [Association of HLA-DRB genes with Vogt-Koyanagi-Harada syndrome in a Chinese Han population].
Zhang M; Qiu C; Hu T
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2000 Feb; 22(1):36-40. PubMed ID: 12903490
[TBL] [Abstract][Full Text] [Related]
70. Vogt-Koyanagi-Harada disease in an adolescent boy.
Bilgiç Ö; Gündüz A; Kaya K
Pediatr Dermatol; 2014; 31(1):99-101. PubMed ID: 23869531
[TBL] [Abstract][Full Text] [Related]
71. Requirement of Ia-positive nylon wool adherent cells for activation of cytotoxic T-lymphocytes specific to melanocyte-associated antigens in patients with Vogt-Koyanage-Harada's disease.
Maezawa N; Yano A
Jpn J Ophthalmol; 1988; 32(3):348-57. PubMed ID: 3265967
[TBL] [Abstract][Full Text] [Related]
72. Decreased interleukin-37 expression in Vogt-Koyanagi-Harada disease and upregulation following immunosuppressive treatment.
Ye Z; Wang C; Tang J; Zhou Y; Bai L; Liu Y; Kijlstra A; Yang P
J Interferon Cytokine Res; 2015 Apr; 35(4):265-72. PubMed ID: 25343528
[TBL] [Abstract][Full Text] [Related]
73. Human CD4+ T cells specifically recognize a shared melanoma-associated antigen encoded by the tyrosinase gene.
Topalian SL; Rivoltini L; Mancini M; Markus NR; Robbins PF; Kawakami Y; Rosenberg SA
Proc Natl Acad Sci U S A; 1994 Sep; 91(20):9461-5. PubMed ID: 7937789
[TBL] [Abstract][Full Text] [Related]
74. [Surface marker studies of cerebrospinal fluid lymphocytes in Vogt-Koyanagi-Harada diseases].
Okubo K; Kurimoto S; Okubo K; Yokoyama MM
Nippon Ganka Gakkai Zasshi; 1985 Jun; 89(6):726-32. PubMed ID: 3877406
[No Abstract] [Full Text] [Related]
75. Vogt-Koyanagi-Harada (VKH) syndrome: A new perspective for healthcare professionals.
Patil YB; Garg R; Rajguru JP; Sirsalmath M; Bevinakatti VA; Kumar M; Sharma S
J Family Med Prim Care; 2020 Jan; 9(1):31-35. PubMed ID: 32110561
[TBL] [Abstract][Full Text] [Related]
76. KIR and HLA Genotypes Implicated in Reduced Killer Lymphocytes Immunity Are Associated with Vogt-Koyanagi-Harada Disease.
Levinson RD; Yung M; Meguro A; Ashouri E; Yu F; Mizuki N; Ohno S; Rajalingam R
PLoS One; 2016; 11(8):e0160392. PubMed ID: 27490240
[TBL] [Abstract][Full Text] [Related]
77. p38{alpha} MAP kinase controls IL-17 synthesis in vogt-koyanagi-harada syndrome and experimental autoimmune uveitis.
Commodaro AG; Bombardieri CR; Peron JP; Saito KC; Guedes PM; Hamassaki DE; Belfort RN; Rizzo LV; Belfort R; de Camargo MM
Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3567-74. PubMed ID: 20164464
[TBL] [Abstract][Full Text] [Related]
78. HLA-DRB1 and -DQB1 alleles in mestizo patients with Vogt-Koyanagi-Harada's disease in Southern California.
Levinson RD; See RF; Rajalingam R; Reed EF; Park MS; Rao NA; Holland GN
Hum Immunol; 2004 Dec; 65(12):1477-82. PubMed ID: 15603876
[TBL] [Abstract][Full Text] [Related]
79. [High inducibility of Epstein-Barr virus replication in B lymphocytes in Vogt-Koyanagi-Harada disease].
Minoda H; Sakai J; Sugiura M; Imai S; Osato T; Usui M
Nippon Ganka Gakkai Zasshi; 1999 Apr; 103(4):289-96. PubMed ID: 10339973
[TBL] [Abstract][Full Text] [Related]
80. Association between Vogt-Koyanagi-Harada syndrome and HLA-DR1 and -DR4 in Hispanic patients living in southern California.
Weisz JM; Holland GN; Roer LN; Park MS; Yuge AJ; Moorthy RS; Forster DJ; Rao NA; Terasaki PI
Ophthalmology; 1995 Jul; 102(7):1012-5. PubMed ID: 9121744
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
